Miguel Guzman-Rivero

Dr. Miguel Guzman-Rivero

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
ECErnesto Rojas Cabrera
Ernesto Rojas Cabrera
AVAleida Verduguez-Orellana
Aleida Verduguez-Orellana
ITIgberto J. Tordoya-Titichoca
Igberto J. Tordoya-Titichoca
CSCcoya Sejas
Ccoya Sejas
RLRebeca Ledezma
Rebeca Ledezma
MGMiguel Guzman-Rivero
Miguel Guzman-Rivero
The standard of care for cutaneous leishmaniasis includes the intramuscular/intravenous administration of pentavalent antimonials that are toxic and poorly tolerated. Primary health care usually lacks trained health staff for the diagnosis and treatment of leishmaniasis in Cochabamba Bolivia. Taking these aspects into account, a Bolivian consortium set out to explore the intralesional administration of meglumine antimoniate to treat cutaneous leishmaniasis during primary care under programmatic conditions. A four-step strategy consisting of clinical training for intralesional treatment and the promotion and periodic follow-up of health staff was carried out. The training process was applied in situ to personnel of nine primary health care centres. The intralesional treatment was applied five times every other day. Clinical follow-up after six-months of treatment showed a 77% healing proportion and 5% of therapeutic failure among 152 enrolled patients. The drug volume used in the intralesional procedure was on average 1.7 mL/ulcer treated. In conclusion, the strategy used was successful and effective, accomplishing a healing proportion similar to the long standardized treatment with a reduced time of administration, no severe side effects, and it is feasible to conduct by trained health staff. Our study supports the current PAHO/WHO recommendation for the intralesional administration of pentavalent antimonials for the treatment of cutaneous leishmaniasis.

1 November 2023 in IJID Regions
Verified
Journal Article
Open access
Jhonny Limachi-ChoqueJhonny Limachi-Choque
Jhonny Limachi-Choque
JGJavier Guitian
Javier Guitian
CLChristine Leyns
Christine Leyns
MGMiguel Guzman-Rivero
Miguel Guzman-Rivero
DEDaniel Eid
Daniel Eid
This study aimed to ascertain which factors are associated with higher risk of mortality among hospitalized COVID-19 Bolivian patients. This retrospective observational study assessed risk factors associated with mortality in patients (n = 549) hospitalized for SARS-CoV-2 infection in a Bolivian hospital between April 6, 2020, and August 18, 2022. The results provide evidence of association between male sex (odds ratio [OR] = 1.6, 95% confidence interval [CI] 1.06-2.6), older age, 51-61 years-old (OR = 5.2, 95% CI 2.2-12.6), 62-70 years-old (OR = 8.7, 95% CI 3.7-20.5), >70 years-old (OR = 16.9, 95% CI 7.1-39.9), and blood group A (OR = 1.9, 95% CI: 1.1-3.4) with higher mortality risk. The strong association between mortality and relatively young age, may be due to high frequency of undiagnosed comorbidities. Vaccination was associated with a reduction in mortality only when time period of hospitalization was not adjusted for. Among hospitalized patients in Bolivia male sex, older age, and blood group A are associated with higher mortality risk. Mortality risk increased markedly from a relatively young age and decreased in parallel to the uptake of the vaccination program. However, the gradual reduction in mortality can also be due to improved patient management and changes in natural immunity and virulence of circulating strains as the pandemic progressed.

3 July 2023
Verified
Preprint
Open access
PDF file
MGMiguel Guzman-Rivero
Miguel Guzman-Rivero
Interesting manuscript. Is clear in the concepts and in the presentation of arguments regarding the trajectory of Covid-19 disease and its effect on immunity evolution against SARS-CoV-2 virus variants.

11 October 2023
Verified
Preprint
Open access
PDF file
MGMiguel Guzman-Rivero
Miguel Guzman-Rivero
The participation of α7 nAChRs (α7 Nicotinic Acetylcholine Receptor) in the development of Post Acute Sequelae of COVID-19 (PASC), according to the authors, based on previous evidence described in other publications and their own, is very interesting...

1 November 2022 in Ciencia Latina Revista Científica Multidisciplinar
Verified
Journal Article
Open access
PDF file
MGMaría Fernanda Ayala Guzmán
María Fernanda Ayala Guzmán
MGMiguel Guzman-Rivero
Miguel Guzman-Rivero
VMViviana Medrano
Viviana Medrano
El virus SARS-CoV-2, causante de la enfermedad COVID-19, produce una infección que puede evolucionar a casos severos de COVID-19 como resultado de una inadecuada y descontrolada respuesta inmunológica caracterizada por la liberación masiva de citocinas proinflamatorias, las cuales constituyen parte de la respuesta inmune innata y son importantes para el control de las infecciones. El objetivo de la presente revisión fue evidenciar la importancia de la acción pleiotrópica de las citocinas proinflamatorias que conducen a un estado hiper activado de respuesta inmune con grave afectación tisular orgánico ocasionado alteraciones funcionales severas, por lo que se considera, en base a la revisión de la información disponible, como imperiosa la determinación de la concentración plasmática de estas citocinas como biomarcadores precoces, confiables de la evolución de la COVID-19.

31 July 2023
Verified
Preprint
Open access
PDF file
MGMiguel Guzman-Rivero
Miguel Guzman-Rivero
The manuscript is interesting. In my opinion, it provides compelling evidence on the appearance of new variants in the context of the SARS-CoV-2 pandemic, supported by the selection-limited hypothesis rather than the mutation-limited one. The knowled...